- Home
- PHAR vs SENEA Comparison
PHAR vs SENEA Comparison
Compare PHAR & SENEA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAR
- SENEA
- Stock Information
- Founded
- PHAR 1988
- SENEA 1949
- Country
- PHAR Netherlands
- SENEA United States
- Employees
- PHAR N/A
- SENEA N/A
- Industry
- PHAR Biotechnology: Pharmaceutical Preparations
- SENEA Packaged Foods
- Sector
- PHAR Health Care
- SENEA Consumer Staples
- Exchange
- PHAR Nasdaq
- SENEA Nasdaq
- Market Cap
- PHAR 707.9M
- SENEA 699.2M
- IPO Year
- PHAR N/A
- SENEA N/A
- Fundamental
- Price
- PHAR $10.96
- SENEA $103.44
- Analyst Decision
- PHAR Strong Buy
- SENEA
- Analyst Count
- PHAR 3
- SENEA 0
- Target Price
- PHAR $30.00
- SENEA N/A
- AVG Volume (30 Days)
- PHAR 5.3K
- SENEA 68.0K
- Earning Date
- PHAR 07-31-2025
- SENEA 08-11-2025
- Dividend Yield
- PHAR N/A
- SENEA N/A
- EPS Growth
- PHAR N/A
- SENEA N/A
- EPS
- PHAR N/A
- SENEA 5.90
- Revenue
- PHAR $339,836,000.00
- SENEA $1,578,887,000.00
- Revenue This Year
- PHAR $12.88
- SENEA N/A
- Revenue Next Year
- PHAR $8.54
- SENEA N/A
- P/E Ratio
- PHAR N/A
- SENEA $17.75
- Revenue Growth
- PHAR 22.44
- SENEA 8.25
- 52 Week Low
- PHAR $6.73
- SENEA $56.36
- 52 Week High
- PHAR $12.61
- SENEA $107.36
- Technical
- Relative Strength Index (RSI)
- PHAR 58.06
- SENEA 55.67
- Support Level
- PHAR $9.54
- SENEA $100.59
- Resistance Level
- PHAR $10.46
- SENEA $107.36
- Average True Range (ATR)
- PHAR 0.37
- SENEA 2.51
- MACD
- PHAR 0.10
- SENEA -0.25
- Stochastic Oscillator
- PHAR 81.20
- SENEA 46.81
About PHAR Pharming Group N.V.
Pharming Group is a biopharmaceutical company focused in transforming the lives of patients with rare, debilitating, and life-threatening diseases. The company is actively developing and commercializing a diverse portfolio of innovative treatments, including both biologics and small molecule therapies. Its commercial products are RUCONEST, approved for the treatment of acute attacks in adult and adolescent patients with hereditary angioedema, or HAE; and Joenja (leniolisib), a small-molecule kinase inhibitor, developed for the treatment of activated phosphoinositide 3-kinase delta syndrome.
About SENEA Seneca Foods Corp.
Seneca Foods Corp is a US-based company which acts as a provider of packaged fruits and vegetables. Its product offerings include canned, frozen, and bottled produce and snack chips. The company's segment includes Vegetable and Fruit/Snack. It generates maximum revenue from the Vegetable segment.